SK105499A3 - Dna comprising one or more genes specific for biosythesis of 5s clavam in s. clavuligerus, a vector containing dna, a host containing such vectors, process for improving the manufacture of 5r clavam and method for identification of microorganisms - Google Patents

Dna comprising one or more genes specific for biosythesis of 5s clavam in s. clavuligerus, a vector containing dna, a host containing such vectors, process for improving the manufacture of 5r clavam and method for identification of microorganisms Download PDF

Info

Publication number
SK105499A3
SK105499A3 SK1054-99A SK105499A SK105499A3 SK 105499 A3 SK105499 A3 SK 105499A3 SK 105499 A SK105499 A SK 105499A SK 105499 A3 SK105499 A3 SK 105499A3
Authority
SK
Slovakia
Prior art keywords
clavam
dna
clavuligerus
clavulanic acid
orfup
Prior art date
Application number
SK1054-99A
Other languages
English (en)
Slovak (sk)
Inventor
Barry Barton
John Patrick Griffin
Cecilia Anders
Susan Jensen
Roy Henry Mosher
Ashish Sudhakar Paradkar
Original Assignee
Smithkline Beecham Plc
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Univ Alberta filed Critical Smithkline Beecham Plc
Publication of SK105499A3 publication Critical patent/SK105499A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1054-99A 1997-02-04 1998-02-02 Dna comprising one or more genes specific for biosythesis of 5s clavam in s. clavuligerus, a vector containing dna, a host containing such vectors, process for improving the manufacture of 5r clavam and method for identification of microorganisms SK105499A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9702218.0A GB9702218D0 (en) 1997-02-04 1997-02-04 Novel product
PCT/EP1998/000644 WO1998033896A2 (en) 1997-02-04 1998-02-02 Microorganisms with increased production of clavulanic acid

Publications (1)

Publication Number Publication Date
SK105499A3 true SK105499A3 (en) 2000-05-16

Family

ID=10807030

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1054-99A SK105499A3 (en) 1997-02-04 1998-02-02 Dna comprising one or more genes specific for biosythesis of 5s clavam in s. clavuligerus, a vector containing dna, a host containing such vectors, process for improving the manufacture of 5r clavam and method for identification of microorganisms

Country Status (32)

Country Link
US (5) US6936458B1 (es)
EP (2) EP1405913A3 (es)
JP (2) JP4227199B2 (es)
KR (2) KR100514964B1 (es)
CN (2) CN1192107C (es)
AP (1) AP1320A (es)
AR (2) AR011100A1 (es)
AT (1) ATE312926T1 (es)
AU (1) AU735782B2 (es)
BG (1) BG103704A (es)
BR (1) BR9807144A (es)
CA (1) CA2279207A1 (es)
DE (1) DE69832783T2 (es)
DZ (1) DZ2413A1 (es)
EA (1) EA003773B1 (es)
ES (1) ES2255149T3 (es)
GB (1) GB9702218D0 (es)
HU (1) HUP0001048A3 (es)
ID (1) ID22144A (es)
IL (1) IL131043A0 (es)
MA (1) MA24464A1 (es)
MY (1) MY140928A (es)
NO (1) NO993758D0 (es)
NZ (1) NZ336894A (es)
OA (1) OA11082A (es)
PL (1) PL334961A1 (es)
SK (1) SK105499A3 (es)
TR (1) TR199901862T2 (es)
TW (2) TW200307041A (es)
UY (2) UY24874A1 (es)
WO (1) WO1998033896A2 (es)
ZA (1) ZA98868B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019959A1 (en) * 1999-09-16 2001-03-22 The Johns Hopkins University Improvement of clavulanic acid production
EP1228218A2 (en) * 1999-10-22 2002-08-07 Smithkline Beecham Plc 5r clavam producing microorganisms with deleted lat and cvm genes
GB0308696D0 (en) * 2003-04-15 2003-05-21 Glaxo Group Ltd New process
EP2589663A1 (en) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Process for production of clavulanic acid
CN107964522B (zh) * 2018-01-04 2020-12-08 上海交通大学 海洋链霉菌dut11及其抗补体活性应用
CN114072493A (zh) 2019-07-05 2022-02-18 葛兰素史密斯克莱知识产权(第2 号)有限公司 棒状链霉菌

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
IT1059403B (it) * 1975-02-07 1982-05-31 Glaxo Lab Ltd Procedimento per produrre acido clavulanico e suoi derivati nonche composizioni che lo contengono
GB1585661A (en) 1976-06-08 1981-03-11 Glaxo Lab Ltd Clavam derivatives
JPS589679B2 (ja) 1977-02-24 1983-02-22 武田薬品工業株式会社 抗生物質の製造法
US4202819A (en) 1979-05-04 1980-05-13 Hoffman-La Roche Inc. 2-(3-Alanyl)clavam antibiotic
GB8521516D0 (en) * 1985-08-29 1985-10-02 Beecham Group Plc Compounds
GB9020683D0 (en) 1990-09-22 1990-11-07 Univ Strathclyde Isolation of dna
CA2108113C (en) * 1993-10-08 2006-12-05 Susan E. Jensen Dna sequence encoding enzymes of clavulanic acid biosynthesis

Also Published As

Publication number Publication date
AR018304A2 (es) 2001-11-14
AP9901614A0 (en) 1999-09-30
DE69832783T2 (de) 2006-07-20
ID22144A (id) 1999-09-09
UY24874A1 (es) 2001-07-31
WO1998033896A2 (en) 1998-08-06
JP4227199B2 (ja) 2009-02-18
EP1405913A2 (en) 2004-04-07
HUP0001048A2 (hu) 2000-08-28
WO1998033896A3 (en) 1998-11-19
HUP0001048A3 (en) 2001-09-28
UY25197A1 (es) 1998-11-27
MA24464A1 (fr) 1998-10-01
JP2001511001A (ja) 2001-08-07
US20030166175A1 (en) 2003-09-04
JP5042186B2 (ja) 2012-10-03
US6936458B1 (en) 2005-08-30
US7344869B2 (en) 2008-03-18
NO993758L (no) 1999-08-03
US20030022321A1 (en) 2003-01-30
AR011100A1 (es) 2000-08-02
CN1192107C (zh) 2005-03-09
TW200307041A (en) 2003-12-01
DZ2413A1 (fr) 2003-01-04
ES2255149T3 (es) 2006-06-16
GB9702218D0 (en) 1997-03-26
AU735782B2 (en) 2001-07-12
TR199901862T2 (xx) 2000-12-21
IL131043A0 (en) 2001-01-28
PL334961A1 (en) 2000-03-27
EP0970198B1 (en) 2005-12-14
CN1696301A (zh) 2005-11-16
EP0970198A2 (en) 2000-01-12
KR20000070723A (ko) 2000-11-25
US20070298470A1 (en) 2007-12-27
ATE312926T1 (de) 2005-12-15
ZA98868B (en) 1999-08-03
EP1405913A3 (en) 2004-08-04
AU6295398A (en) 1998-08-25
NZ336894A (en) 2001-08-31
CA2279207A1 (en) 1998-08-06
TW589377B (en) 2004-06-01
EA199900718A1 (ru) 2000-02-28
AP1320A (en) 2004-10-29
JP2009022298A (ja) 2009-02-05
KR100514964B1 (ko) 2005-09-15
KR20050053794A (ko) 2005-06-08
EA003773B1 (ru) 2003-08-28
NO993758D0 (no) 1999-08-03
OA11082A (en) 2003-03-13
CN1251612A (zh) 2000-04-26
US20030124690A1 (en) 2003-07-03
DE69832783D1 (de) 2006-01-19
BG103704A (en) 2000-05-31
BR9807144A (pt) 2000-01-25
MY140928A (en) 2010-02-12

Similar Documents

Publication Publication Date Title
JPH09107981A (ja) ホスフィノトリシン耐性遺伝子の使用
CA2767491C (en) Process for preparation of tacrolimus
JP5042186B2 (ja) 多量のクラブラン酸を産生する微生物
Hung et al. Enhancement of clavulanic acid by replicative and integrative expression of ccaR and cas2 in Streptomyces clavuligerus NRRL3585
WO2002059322A9 (en) Compositions and methods relating to the daptomycin biosynthetic gene cluster
KR102159415B1 (ko) Uk-2 생합성 유전자 및 그것을 사용한 uk-2 생산성을 향상시키기 위한 방법
JP2007289193A6 (ja) クラバム抗生物質の産生を強化する方法
JP2007289193A (ja) クラバム抗生物質の産生を強化する方法
CZ277599A3 (cs) Mikroorganismy se zvýšenou produkcí kyseliny klavulanové
US7622302B1 (en) Process for improving the manufacture of clavams e.g. clavulanic acid
US6410293B1 (en) DNA fragments containing biotin biosynthetase gene and use of the same
US20030109694A1 (en) Novel process
JPH06105682A (ja) β−ラクタム抗生物質産生促進法および大量のACVシンテターゼ単離法
Jensen Genetic Engineering To Regulate Production of Secondary Metabolites in Streptomyces clavuligerus
KR19990074514A (ko) 아미노글라이코사이드계 항생제에 대해 다제내성을지정하는유전자